Generi Biotech

Generi Biotech is a company in Hradec Kralove, Czech Republic that has taken part in 2 EU-funded projects since 2010, receiving €523k in EU funding.

EU funding received€523k
EU projects2
As coordinator0
Running now0
First EU project2010
Latest project2012
CountryCzech Republic
EU registration (PIC)996747945
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Generi Biotech's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€523k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • INTENSOPartner

    Gaining Productivity, Cost Efficiency and Sustainability in the Downstreaming Processing of Bio Products by novel Integration and Intensification strategies

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €301ktheir share
  • DINAMOPartner

    DEVELOPMENT OF DIAMOND INTRACELLULAR NANOPROBES FOR ONCOGEN TRANSFORMATION DYNAMICS MONITORING IN LIVING CELLS

    FP7 (2007 to 2013) · 2010–2013 · Project on CORDIS ↗

    €222ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • fermentation
  • molecular biology
  • nanotechnology
  • oncology
  • pharmacology and pharmacy
  • productivity
  • virology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime